Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
Public ClinicalTrials.gov record NCT05028582. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized tRial Employing topiCal roflumilasT Foam to Treat Scalp Psoriasis (ARRECTOR)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a parallel group, double blind, vehicle-controlled study to assess the safety and efficacy of roflumilast (ARQ-154) 0.3% foam vs vehicle foam applied once daily (qd) for 8 weeks by participants with plaque psoriasis of the scalp and body.
Study identification
- NCT ID
- NCT05028582
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 432 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 24, 2021 (Actual)
- Primary completion
- Jun 3, 2022 (Actual)
- Completion
- Jun 3, 2022 (Actual)
- Last update posted
- Jul 17, 2025
2021 – 2022
United States locations
- U.S. sites
- 36
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arcutis Biotherapeutics Clinical Site 01 | Scottsdale | Arizona | 85255 | — |
| Arcutis Biotherapeutics Clinical Site 50 | Beverly Hills | California | 90212 | — |
| Arcutis Biotherapeutics Clinical Site 45 | Encinitas | California | 92024 | — |
| Arcutis Biotherapeutics Clinical Site 64 | San Diego | California | 92123 | — |
| Arcutis Biotherapeutics Clinical Site 72 | Santa Ana | California | 92701 | — |
| Arcutis Biotherapeutics Clinical Site 21 | Santa Monica | California | 90404 | — |
| Arcutis Biotherapeutics Clinical Site 33 | Clearwater | Florida | 33756 | — |
| Arcutis Biotherapeutics Clinical Site 42 | Coral Gables | Florida | 33134 | — |
| Arcutis Biotherapeutics Clinical Site 57 | Delray Beach | Florida | 33484 | — |
| Arcutis Biotherapeutics Clinical Site 31 | North Miami Beach | Florida | 33162 | — |
| Arcutis Biotherapeutics Clinical Site 05 | Orlando | Florida | 32819 | — |
| Arcutis Biotherapeutics Clinical Site 65 | Sanford | Florida | 32771 | — |
| Arcutis Biotherapeutics Clinical Site 12 | Tampa | Florida | 33613 | — |
| Arcutis Biotherapeutics Clinical Site 22 | Plainfield | Illinois | 46168 | — |
| Arcutis Biotherapeutics Clinical Site 10 | Rolling Meadows | Illinois | 60008 | — |
| Arcutis Biotherapeutics Clinical Site 15 | Louisville | Kentucky | 40217 | — |
| Arcutis Biotherapeutics Clinical Site 04 | Lake Charles | Louisiana | 70605 | — |
| Arcutis Biotherapeutics Clinical Site 02 | Rockville | Maryland | 20850 | — |
| Arcutis Biotherapeutics Clinical Site 28 | Rockville | Maryland | 20850 | — |
| Arcutis Biotherapeutics Clinical Site 20 | Detroit | Michigan | 48202 | — |
| Arcutis Biotherapeutics Clinical Site 14 | New Brighton | Minnesota | 55112 | — |
| Arcutis Biotherapeutics Clinical Site 44 | Saint Joseph | Missouri | 64506 | — |
| Arcutis Biotherapeutics Clinical Site 34 | East Windsor | New Jersey | 08520 | — |
| Arcutis Biotherapeutics Clinical Site 51 | Rochester | New York | 14623 | — |
| Arcutis Biotherapeutics Clinical Site 63 | The Bronx | New York | 10462 | — |
| Arcutis Biotherapeutics Clinical Site 23 | High Point | North Carolina | 27262 | — |
| Arcutis Biotherapeutics Clinical Site 25 | Portland | Oregon | 97223 | — |
| Arcutis Biotherapeutics Clinical Site 27 | Pittsburgh | Pennsylvania | 15213 | — |
| Arcutis Biotherapeutics Clinical Site 06 | Knoxville | Tennessee | 37922 | — |
| Arcutis Biotherapeutics Clinical Site 13 | Arlington | Texas | 76011 | — |
| Arcutis Biotherapeutics Clinical Site 11 | Austin | Texas | 78759 | — |
| Arcutis Biotherapeutics Clinical Site 41 | College Station | Texas | 77845 | — |
| Arcutis Biotherapeutics Clinical Site 54 | San Antonio | Texas | 78213 | — |
| Arcutis Biotherapeutics Clinical Site 24 | San Antonio | Texas | 78218 | — |
| Arcutis Biotherapeutics Clinical Site 07 | West Jordan | Utah | 84088 | — |
| Arcutis Biotherapeutics Clinical Site 17 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05028582, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2025 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05028582 live on ClinicalTrials.gov.